Detalhe da pesquisa
1.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1289-1300, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616314
2.
AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK.
PLoS Comput Biol
; 19(5): e1010263, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37235579
3.
Correction: AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK.
PLoS Comput Biol
; 19(11): e1011672, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992014
4.
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Future Oncol
; 20(7): 351-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994649
5.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol
; 24(3): 228-238, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858721
6.
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab.
Oncologist
; 28(6): 501-509, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866412
7.
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Lancet Oncol
; 20(6): 837-848, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078463
8.
Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
J Vasc Interv Radiol
; 28(3): 342-348, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993507
9.
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
N Engl J Med
; 369(8): 722-31, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23964934
10.
In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer.
Breast Cancer Res Treat
; 149(1): 99-108, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519042
11.
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
Pancreatology
; 15(6): 667-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412296
12.
Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort.
Eur J Cancer
; 196: 113434, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008031
13.
Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells.
Mol Carcinog
; 52(3): 218-28, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22121107
14.
Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
Nat Rev Urol
; 20(1): 48-60, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192502
15.
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.
J Clin Oncol
; 41(1): 22-31, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041086
16.
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669791
17.
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.
BMC Cancer
; 12: 199, 2012 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22642850
18.
Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma.
iScience
; 25(12): 105621, 2022 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36465101
19.
Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600561
20.
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin.
Clin Genitourin Cancer
; 20(1): 11-16, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503934